期刊文献+

我国基层医疗卫生机构基本药物补偿模式及利弊分析 被引量:3

Compensation Mode and Analysis of the Pros and Cons of Essential Drugs in Primary Health Care Institutions in China
暂未订购
导出
摘要 目的完善我国基本药物补偿机制,为进一步推进国家基本药物制度提供参考。方法总结归纳我国基层医疗卫生机构基本药物补偿模式,探讨基本药物补偿中存在的问题,提出策略建议。结果与结论目前我国基层医疗卫生机构基本药物补偿模式主要有多种渠道(多头补偿)、定额补偿、以奖代补、奖补结合和政府全额补助5种模式;各地方在采用不同补偿模式时要注意充分利用该补偿模式的优势并规避其劣势。 Objective To improve the compensation mechanism of essential drugs, providing a reference for further improving the national essential drug system in China. Methods After summarizing the essential drug compensation mode in our primary health care facilities and discussing the problems in essential drug compensation, strategy recommendations were proposed. Results and Conclusion Current essential drug compensation modes in our primary health care facilities, include multiple channel compensation (long position compensation), the fixed compensation, reward instead of compensation, combination of rewards and compensation and full governmental subsidy.
作者 李花 陈玉文
出处 《中国药事》 CAS 2014年第2期138-140,146,共4页 Chinese Pharmaceutical Affairs
关键词 基本药物制度 基层医疗机构 补偿模式 利弊分析 essential medicine system primary health care facilities compensation mode analysis of advantages and disadvantages
  • 相关文献

参考文献8

二级参考文献23

共引文献54

同被引文献61

  • 1中共中央,国务院.关于深化医药卫生体制改革的意见[Z].2009.
  • 2Shi L, Yang H, Cheng G, et al. Time trends and determi- nants of pharmaceutical expenditure in China (1990 - 2009) [ J]. PharmaeoEconomics, 2014, 32 (3) : 257-264.
  • 3Xiao Y, Zhao K, Bishai D M, et al. Essential drugs policy in three rural counties in China: what does a complexity lens add? [J]. Social Science & Medicine, 2013,93: 220-228.
  • 4Hogerzeil H V, Liberman J, Wirtz V J, et al. Promotion of access to essential medicines for non-communicable disea- ses: practical implications of the UN political declaration [J]. The Lancet, 2013, 381(9867): 680-689.
  • 5Yip W C, Hsiao W C, Chen W, et al. Early appraisal of China's huge and complex health-care reforms [ J ]. The Lan- cet, 2012, 379(9818): 833-842.
  • 6WHO: Regional framework for action on access to essential medicines in the Western Pacific (2011-2016). [2015-01-15]. http ://www. wpro. who. int/publications/PUB_9789290615705/ en/index, html.
  • 7Fang Y, Wagner A K, Yang S, et al. Access to affordable medicines after health reform: evidence from two cross-sec- tional surveys in Shaanxi Province, western China[ J]. The Lancet Global Health, 2013, 1 (4) : e227-e237.
  • 8Jiang M, Yang S, Yan K, et al. Measuring access to medi- cines: a survey of prices, availability and affordability in Shaanxi Province of China [ J ]. PloS One, 2013, 8 (8) : e70836.
  • 9Yang H, Dib H H, Zhu M, et al. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China[ J]. Health Policy and Planning, 2010, 25(3) : 219-229.
  • 10Yang S, Fang Y. Medicine prices, availability and afford- ability survey in Shaanxi Province, Western China [ R]. 2010.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部